Comment on FDA Approves World’s First Crispr Gene-Editing Drug for Sickle-Cell Disease | Landmark decision heralds a new type of medicine that can tackle genetic conditions that are hard to treat

JohnDClay@sh.itjust.works ⁨1⁩ ⁨year⁩ ago

• silence7@slrpnk.net ⁨1⁩ ⁨year⁩ ago

  The pricing is higher than you’re describing - about 2 million dollars, which is still cheaper than paying for ongiong treatment over the course of a person’s life.

  It’s priced to be attractive to corporate-sponsored insurance plans, not for individuals to pay out of pocket.

  source

  • JohnDClay@sh.itjust.works ⁨1⁩ ⁨year⁩ ago

    But the corporate sponsored insurance plans still need to be payed for somehow, usually as a deduction in what the company would pay since they can advertise better benefits. My friend’s family has sickle cell, but I guess this won’t help them since he’s a car salesman.

    source

    • silence7@slrpnk.net ⁨1⁩ ⁨year⁩ ago

      They pay for it by not having to cover the expense of treating the disease anymore. It’s an incredibly expensive disease to manage as a chronic condition.

      source
    • threelonmusketeers@sh.itjust.works ⁨1⁩ ⁨year⁩ ago

      payed

      I think the word you’re looking for is “paid”. “Payed” is something to do with sailors and ropes or something.

      I am not a bot and this action was performed manually.

      source
• DemBoSain@midwest.social ⁨1⁩ ⁨year⁩ ago

  It’s very expensive, but it’s also a very intensive treatment. As I understand, they harvest stem cells, and those are modified with CRISPR. Meanwhile, they give the patient chemo-therapy to destroy all the bone-marrow. Then the modified stem-cells are placed in the body to regenerate the bone marrow.

  I’m not educated to understand any of this, so hopefully someone can expand.

  source